Literature DB >> 15883039

Therapeutic effects of PG201, an ethanol extract from herbs, through cartilage protection on collagenase-induced arthritis in rabbits.

Kyoung Chul Park1, Eun Jin Park, Eun Ran Kim, Yeonran Kim, Suk Hee Chung, Byoung Wook Cho, Sunyoung Kim, Mirim Jin.   

Abstract

In order to assess the therapeutic effects of PG201 (an ethanol extract from herbs) on osteoarthritis, we investigated whether PG201 could suppress the disease progression of collagenase-induced arthritis (CNIA) in rabbits. The right knees of rabbits were injected intra-articularly with collagenase, and the rabbits were orally treated with distilled water (DW), PG201 (200 mg/kg) or diclofenac (DCF, 10 mg/kg) once a day for 8 weeks. Oral administration of PG201 significantly suppressed the stiffness and bone space narrowing. Cartilage erosion and GAG release (p<0.01) were considerably reduced in the knee joints. As well, the mRNA expression of matrix degradation enzymes including MMP-1, -3, and -13 was decreased. On the contrary, the concentrations of TIMP-2 in the synovial fluids were considerably amplified in the PG201 treated group (p<0.01), but not in the DCF treated group. The pathologic inflammatory molecules involved in cartilage destruction such as IL-1beta, PGE2, and NO were also diminished by PG201. Taken together, these results indicate that PG201 has therapeutic effects on CNIA through the prominent protection of cartilage. PG201 indeed has great potential as a form of treatment for osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15883039     DOI: 10.1016/j.bbrc.2005.04.030

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Efficacy and safety of PG201 (Layla(®)) and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study.

Authors:  Wan-Hee Yoo; Han-Gyul Yoo; Sung-Hwan Park; Han-Joo Baek; Yun Jong Lee; Seung Cheol Shim; Seong Wook Kang; Hyun Ah Kim; Jung Soo Song; Chang Hee Suh; Sung Jae Choi; Bo Young Yoon; Dong Nyeon Tae; Hyun Sook Ko; Yeong-Wook Song
Journal:  Rheumatol Int       Date:  2014-02-16       Impact factor: 2.631

2.  Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.

Authors:  Kelly Coffey; Timothy J Blackburn; Susan Cook; Bernard T Golding; Roger J Griffin; Ian R Hardcastle; Lorraine Hewitt; Kety Huberman; Hesta V McNeill; David R Newell; Celine Roche; Claudia A Ryan-Munden; Anna Watson; Craig N Robson
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

3.  New herbal composition (OA-F2) protects cartilage degeneration in a rat model of collagenase induced osteoarthritis.

Authors:  Pallavi S Nirmal; Suresh D Jagtap; Aarti N Narkhede; Bhagyashri E Nagarkar; Abhay M Harsulkar
Journal:  BMC Complement Altern Med       Date:  2017-01-03       Impact factor: 3.659

Review 4.  Natural Products as Sources of Novel Drug Candidates for the Pharmacological Management of Osteoarthritis: A Narrative Review.

Authors:  Young-Hoon Kang; Hyun Jae Lee; Choong Jae Lee; Jin-Sung Park
Journal:  Biomol Ther (Seoul)       Date:  2019-11-01       Impact factor: 4.634

Review 5.  Intersection of inflammation and herbal medicine in the treatment of osteoarthritis.

Authors:  Ali Mobasheri
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.